About this trial
AMI Survivors who participated in the project "Construction and key technology research of the whole myocardial protection system for acute myocardial infarction" (project number 2016YFC1301100) and completed the 1-year visit were followed up by telephone at 3 years (within the corresponding follow-up time window) and 5 years after discharge to acquire the patients' medication, health status, and major adverse cardiovascular and cerebrovascular events, including death, heart failure, rehospitalization, re-myocardial infarction, revascularization, stroke, malignant arrhythmia, and bleeding events.
Eligibility criteria
Qualifiers
AMI survivors who participated in the project "Construction and key technology research of the whole myocardial protection system for acute myocardial infarction" and completed the 1-year visit.
Telephone to obtain informed consent from the subjects/family members of the subjects.
Disqualifiers
Not available
Trial design
Treatments tested in this trial
- Treatment Strategies
Treatment groups
Sponsors and collaborators
Yu Bo
Lead sponsor
Harbin Medical University
Sponsor institution